Statutory notifiable infectious disease | Effective date as statutory notifiable infectious disease |
---|
Severe Acute Respiratory Syndrome | 27 March 2003 |
Influenza A (H5) | 30 January 2004 (see Note 9) |
Japanese encephalitis | 16 July 2004 |
Influenza A (H7) and Influenza A (H9) | 31 December 2004 (see Note 9) |
Streptococcus suis infection | 2 August 2005 |
Community-associated methicillin-resistant Staphylococcus aureus infection | 5 January 2007 |
Anthrax, Botulism, Congenital rubella syndrome, Creutzfeldt-Jakob disease, Escherichia coli O157:H7 infection, Haemophilus influenzae type b infection (invasive), Hantavirus infection, Influenza A (H2), Leptospirosis, Listeriosis, Psittacosis, Q fever, Smallpox, Viral haemorrhagic fever and West Nile Virus Infection | 14 July 2008 (For Influenza A(H2), see Note 9) |
Chikungunya fever and Enterovirus 71 infection | 6 March 2009 |
Swine Influenza | 27 April 2009 (see Note 5) |
Variant Influenza A (H3N2) | 17 August 2012 (see Note 9) |
Middle East Respiratory Syndrome | 28 September 2012 (see Note 8) |
Invasive pneumococcal disease | 9 January 2015 |
Zika Virus Infection | 5 February 2016 |
Coronavirus disease 2019 (COVID-19) | 8 January 2020 (see Note 11) |